Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk

BACKGROUND: Combined oral contraceptive (COC) use reduces epithelial ovarian cancer (EOC) risk. However, little is known about risk with COC use before the first full-term pregnancy (FFTP). METHODS: This Canadian population-based case–control study (2001–2012) included 854 invasive cases/2139 contro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Cook, Linda S, Pestak, Claire R, Leung, Andy CY, Steed, Helen, Nation, Jill, Swenerton, Kenneth, Gallagher, Richard, Magliocco, Anthony, Köbel, Martin, Brooks-Wilson, Angela, Le, Nhu
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2017
Assuntos:
Short Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5243988/
https://ncbi.nlm.nih.gov/pubmed/27959890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.400
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares